Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL6 | P41182 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 2/20 | 0.41 |
| ▸ | CTSS | P25774 | 2/20 | 0.41 |
| ▸ | CTSK | P43235 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.40 |
| ▸ | STK17B | O94768 | 1/20 | 0.39 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.39 |
| ▸ | GALR2 | O43603 | 2/20 | 0.38 |
| ▸ | GALR1 | P47211 | 2/20 | 0.38 |
| ▸ | CTSV | O60911 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4836573 | 0.84 | BCL6 (0.68) | BCL6SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL4839094 | 0.81 | BCL6 (0.54) | BCL6SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL4838606 | 0.81 | SMN1; SMN2 (0.64) | BCL6SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL4829781 | 0.81 | RAB9A (0.65) | BCL6SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL6016979 | 0.81 | BCL6 (0.46) | BCL6SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL4832789 | 0.80 | BCL6 (0.53) | BCL6SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL4841157 | 0.80 | BCL6 (0.53) | BCL6SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL4829776 | 0.80 | BCL6 (0.59) | BCL6SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL4839296 | 0.80 | BCL6 (0.61) | BCL6SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL4837927 | 0.80 | BCL6 (0.55) | BCL6SMN1; SMN2MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7332489-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2008-02-19 | — | — | US | disclosed |
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | BCL6 2097/4885SMN1; SMN2 4172/4885MAPT 3539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.